The Lipidyzer™ Platform: A Revolutionary Tool for Understanding the Role of Lipids in Disease Join us to learn about the key challenges in lipid analysis and how the Lipidyzer platform can help you overcome them.
Walk-Away Monitoring of Cytotoxicity, Viability and Apoptosis Join us to learn how to simplify and automate cell viability and cytotoxicity assessment for your cell analysis workflows.
How to Optimize Sample Preparation Step Prior to Extraction Discover the benefits of bead-binding for sample preparation in this on demand webinar from Bertin Technologies.
The Bru-seq Technology Platform for Nascent RNA analysis Mats Ljungman, Professor, University of Michigan will present a set of novel techniques to analyze many aspects of gene expression based on the capturing of nascent RNA.
Translation of Omic Data into Personalised Oncology Tools The Challenge and the Reward William Gallagher, University College Dublin, speaking at Diagnostics & Biomarkers 2015.
Plasma Vitronectin Predicts Response to Fluoropyrimidine-oxaliplatin (FOLFOX) Chemotherapy in Metastatic Colorectal Cancer Sarah Hayes, University of Sydney, speaking at Diagnostics & Biomarkers 2015.
Parallel Tracking i-biomarkerT Development with Drug Development for Maximum Benefit Kevin Cox, Imanova Limited, speaking at Diagnostics & Biomarkers.
Oncology Biomarker Testing Current US Practice Baseline and Emerging Trends Julia Trosman, Center for Business Models in Healthcare, speaking at Diagnostics & Biomarkers 2015.
Advanced Centrifugal Microfluidics for Point-of-Care Applications Roland Zengerle, University of Freiburg, speaking at Point of Care Diagnostics 2015
Highly-integrated Lab-on-a-chip System for Multiparameter Analysis at the Point-of-care Harald Peter, Fraunhofer Institute for Cell Therapy and Immunology IZI-BB